Schedule for CT image guidance in treating prostate cancer with helical tomotherapy

British Journal of Radiology

Volumn 83, Issue 987, 2010, Pages 241-251

  Beldjoudi, G ^a   Yartsev, S ^a,b   Bauman, G ^a,b   Battista, J ^a,b   Van Dyk, J ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; MALE; MATHEMATICAL COMPUTING; MEGAVOLTAGE RADIOTHERAPY; PATIENT POSITIONING; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RANDOM ERROR; SIMULATION; SYSTEMATIC ERROR; TOMOTHERAPY; TREATMENT PLANNING;

AGED; ALGORITHMS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77749246553     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/28706108     Document Type: Article

References (74)

1. Verellen D, De Ridder M, Storme G. A (short) history of image-guided radiotherapy. Radiother Oncol 2008;86:4-13.
2. Dawson LA, Jaffray DA. Advances in image-guided radiation therapy. J Clin Oncol 2007;25:938-46.
3. White E, Kane G. Radiation medicine practice in the image-guided radiation therapy era: new roles and new opportunities. Semin Radiat Oncol 2007;17:298-305.
4. Xing L, Thorndyke B, Schreibmann E, Yang Y, Li TF, Kim GY, et al. Overview of image guided radiation therapy. Med Dosim 2006;31:91-112.
5. Ippolito E, Mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. IGRT in rectal cancer. Acta Oncol 2008;47:1317-24.
6. Nairz O, Merz F, Deutschmann H, Kopp P, Schöller H, Zehentmayr F. A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol 2008;184:663-7.
7. Redpath AT, Wright P, Muren LP. The contribution of online correction for rotational organ motion in image-guided radiotherapy of the bladder and prostate. Acta Oncol 2008;47:1367-72.
8. O'Neill L, Armstrong J, Buckney S, Assiri M, Cannon M, Holmberg O. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer. Radiother Oncol. 2008;88:61-6.
9. Li HS, Chetty IJ, Enke CA, Foster RD, Willoughby TR, Kupellian PA, et al. Dosimetric consequences of intrafraction prostate motion. Int J Radiat Oncol Biol Phys 2008;71:801-12.
10. McGrath S, Kestin L, Dilworth J, Liang J, Krauss D, Yan D, et al. Adaptive image guided radiotherapy (IGRT) eliminates the risk of geometric miss due to rectal distention in prostate cancer treatment planning: biochemical and clinical evidence of efficacy [Abstract]. Int J Radiat Oncol Biol Phys 2008;72:S324.
11. Wang W, Wu Q, Yan D. Quantitative evaluation of cone beam computed tomography in target volume definition for offline image guided radiation therapy of prostate cancer (Abstract). Int J Radiat Oncol Biol Phys 2008;72:S550-1.
12. Grills, IS, Hugo G, Kestin LL, Galerani AP, Chao KK, Wloch J, et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int Radiat Oncol Biol Phys 2008;70:1045-56.
13. Moseley DJ, White EA, Wiltshire KR, Rosewall T, Sharpe MB, Siewerdsen JH, et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 2007;67:942-53.
14. Poulsen PR, Muren LP, Høyer M. Residual set-up errors and margins in on-line image-guided prostate localization in radiotherapy. Radiother Oncol 2007;85:201-6.
15. Soete G, Verellen D, Michielsen D, Vinh-Hung V, Van de Steene J, Van den Berge D, et al. Clinical use stereoscopic X-ray positioning of patients treated with conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:948-52.
16. Sorcini B, Tilikidis A. Clinical application of image-guided radiotherapy, IGRT (on the Varian OBI platform). Cancer Radiother 2006;10:252-7.
17. Kerkhof EM, Put RW, Raaymakers BW, van der Heide UA, van Vulpen M, Lagendijk JJ. Variation in target and rectum dose due to prostate deformation: an assessment by repeated MR imaging and treatment planning. Phys Med Biol 2008;53:5623-34.
18. Goulet CC, Herman MG, Hillman DW, Davis BJ. Estimated limits of IMRT dose escalation using varied planning target volume margins. Phys Med Biol 2008;53:3777-88.
19. Meijer GJ, de Klerk J, Bzdusek K, van den Berg HA, Janssen R, Kaus MR, et al. What CTV-to-PTV margins should be applied for prostate irradiation? Four-dimensional quantitative assessment using model-based deformable image registration techniques. Int J Radiat Oncol Biol Phys 2008;72:1416-25.
20. Hammoud R, Patel SH, Pradhan D, Kim J, Guan H, Li S, et al. Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomography. Int J Radiat Oncol Biol Phys 2008;71:265-73.
21. Gordon JJ, Siebers JV. Evaluation of dosimetric margins in prostate IMRT treatment plans. Med Phys 2008;35:569-75.
22. Huang SH, Catton C, Jezioranski J, Bayley A, Rose S, Rosewall T. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:1057-64.
23. Zhang M, Moiseenko V, Liu M. PTV margin for dose escalated radiation therapy of prostate cancer with daily online realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysis. J Appl Clin Med Phys 2006;7:38-49.
24. Gordon JJ, Siebers JV. Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors. Phys Med Biol 2007;52:1967-90.
25. Gordon JJ, Crimaldi AJ, Hagan M, Moore J, Siebers JV. Evaluation of clinical margins via simulation of patient setup errors in prostate IMRT treatment plans. Med Phys 2007;34:202-14.
26. Poli ME, Parker W, Patrocinio H, Souhami L, Shenouda G, Campos LL, et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys 2007;67:1430-7.
27. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1121-35.
28. Craig T, Satkusagingham J, Chan K, Brock K, Moseley J, Chung P, et al. Advanced image guidance allows margin reduction in radiation therapy of prostate cancer [Abstract]. Int J Radiat Oncol Biol Phys 2008;72:S551.
29. Amer AM, Mackay RI, Roberts SA, Hendry JH, Williams PC. The required number of treatment imaging days for an effective off-line correction of systematic errors in conformal radiotherapy of prostate cancer. Radiother Oncol 2001;61:143-50.
30. de Boer HCJ, Heijmen BJM. A protocol for the reduction of systematic patient setup errors with minimal portal imaging workload. Int J Radiat Oncol Biol Phys 2001;50:1350-65.
31. Mackie TR, Balog J, Ruchala K, Shepard D, Aldridge S, Fitchard E, et al. Tomotherapy. Sem Radiat Oncol 1999;9:108-17.
32. Mackie TR. History of tomotherapy. Phys Med Biol 2006;51:R427-53.
33. Welsh JS, Patel RR, Ritter MA, Harari PM, Mackie TR, Mehta MP. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Canc Res Treat 2002;1:311-6.
34. Ruchala KJ, Olivera GH, Schloesser EA, Mackie TR. Megavoltage CT on a tomotherapy system. Phys Med Biol 1999;44:2597-621.
35. Tomsej M. The TomoTherapy Hi Art System® for sophisticated IMRT and IGRT with helical delivery: recent developments and clinical applications. Cancer Radiother 2006;10:288-95.
36. Maggiulli E, Broggi S, Pierelli A, Cattaneo G, Canandrino R. 2007 Validation of KVCT-MVCT automatic registration techniques on a helical tomotherapy unit (HT) and estimation of the capabiliuty to point out set-up errors. Proc ICCR 2007;2:180-4.
37. Woodford C, Yartsev S, Van Dyk J. Optimization of megavoltage CT scan registration settings for brain cancer treatments on tomotherapy. Phys Med Biol 2007;52: N185-93.
38. Woodford C, Yartsev S, Van Dyk J. Optimization of megavoltage CT scan registration settings for thoracic cases on helical tomotherapy. Phys Med Biol 2007;52:N345-54.
39. Ramsey CR, Langen KM, Kupelian PA, Scaperoth DD, Meeks SL, Mahan SL, et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2006;64:1237-44.
40. Welsh JS, Lock M, Harary P, Tomé W. Clinical implementation of adaptive helical tomotherapy: A unique approach to image-guided intensity modulated radiotherapy. Technol Canc Res Treat 2006;5:465-80.
41. Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Manadevan A. Impact of image guidance on outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1146-50.
42. Nijkamp J, Pos FJ, Nuver TT, de Jong R, Remeijer P, Sonke JJ, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys 2008;70:75-82.
43. Meeks S, Kupelian PA, Lee C, Willoughby T, Zeidan O, Langen K. Does image guidance need to be performed daily in the treatment of localized prostate cancers? Implications on treatment margins [Abstract]. Int J Radiat Oncol Biol Phys 2007;69:S82-3.
44. Kupelian PA, Lee C, Langen KM, Zeidan OA, Mañon RR, Willoughby TR, et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1151-7.
45. Beldjoudi G, Yartsev S, Battista JJ, Van Dyk J. Optimisation of MVCT imaging schedule in prostate cancer treatment using helical tomotherapy. Cancer Radiother. 2008;12: 316-22.
46. Song WY, Chiu B, Bauman GS, Lock M, Rodrigues G, Ash R, et al. Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2006;65:595-607.
47. Deurloo KE, Steenbakkers RJ, Zijp LJ, de Bois JA, Nowak PJ, Rasch CR, et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int Radiat Oncol Biol Phys 2005;61:228-38.
48. Beltran C, Herman MG, Davis BJ. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiat Oncol Biol Phys 2008;70:289-95.
49. Hoogeman MS, van Herk M, de Bois J, Lebesque JV. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol 2005;74:177-85.
50. Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: Use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 2005;63:141-9.
51. Hugo GD, Yan D, Liang J. Population and patient specific target margins for 4D adaptive radiotherapy to account for intra- and inter-fraction variation in lung tumour position. Phys Med Biol 2007;52:257-74.
52. Bidmead M, Coffey M, Crellin A, Dobbs J, Driver D, Greener T, et al (editors). Geometric uncertainties in radiotherapy: defining the planning target volume. London, UK: British Institute of Radiology, 2003.
53. Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A. An off-line strategy for constructing a patient specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:289-302.
54. Drabik DM, Mackensie MA, Fallone GB. Quantifying appropriate PTV setup margins: analysis of patient setup fidelity and intrafraction motion using post-treatment megavoltage computed tomography scans. Int J Radiat Oncol Biol Phys 2007;68:1222-8.
55. Aubry J, Beaulieu L, Girouard L, Aubin S, Tremblay D, Laverdière J, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 2004;60:30-9.
56. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Yamada S. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med 2005;23:14-24.
57. Chen J, Lee J, Handrahan D, Sause W. Intensity-modualted radiotherapy using implanted fiducal markers with daily portal imaging: assessment of prostate organ motion. Int J Radiat Oncol Biol Phys 2007;68:912-9.
58. Cheung P, Sixel K, Morton G, Loblaw DA, Tirona R, Pang G, et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Oncol Biol Phys 2005;62:418-25.
59. Ghilezan MJ, Jaffray DA, Siewerdsen JH, Van Herk M, Shetty A, Sharpe MB, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int Radiat Oncol Biol Phys 2005;62:406-17.
60. Kitamura K, Shirato H, Seppenwoolde Y, Onimaru R, Oda M, Fujita K, et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys 2002;53:1117-23.
61. Kotte A, Hofman P, Langemdijk JJW, van Vulpen M, van der Heide UA. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial makers. Int J Radiat Oncol Biol Phys 2007;69:419-25.
62. Nederveen AJ, van der Heide UA, Dehnad H, van Moorselaar RJA, Hofman P, Lagendijk JJW. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys 2002;53:206-14.
63. Noel C, Roy M, Parikh PJ, Kupelian P, Mahadevan A, Weinstein G, et al. Are pre and post imaging sufficient to assess intrafraction prostate motion? [Abstract]. Int J Radiat Oncol Biol Phys 2007;69:S22-3.
64. Adamson JD, Wu Q, Yan D, Ghilezan M. Direct measurement of prostate intrafraction motion and residual setup error [Abstract]. Int J Radiat Oncol Biol Phys 2008;72:S549.
65. Litzenberg DW, Balter JM, Hadley SW, Sandler HM, Willoughby TR, Kupelian PA, et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2006;65:548-53.
66. Willoughby TR, Kupelian PA, Pouliot J, Shinohara K, Aubin M, Roach M, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;65:528-34.
67. Kupelian P, Willoughby T, Mahadevan A, Djemil T, Weinstein G, Jani S, et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1088-98.
68. Bortfeld T, van Herk M, Jiang SB. When should systematic patient positioning errors in radiotherapy be corrected? Phys Med Biol 2002;47:N297-302.
69. Stroom JC, de Boer HCJ, Huizenga H, Visser AG. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. J Radiat Oncol Biol Phys 1999;43:905-19.
70. Harsolia AR, Vargas CE, Kestin LL, Yan D, Brabbins DS, Lockman DM, et al. Predictors for chronic urinary toxicity following treatment of prostate cancer with 3-D conformal radiotherapy: dose-volume analysis of a phase II dose escalation study [abstract]. Int J Radiat Oncol Biol Phys 2004;60:S437-8.
71. Kupelian PA, Reddy CA, Carlson TP, Willoughby TR. Dose-volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume? Cancer J 2002;8:62-6.
72. Schaly B, Kempe JA, Bauman GS, Battista JJ, Van Dyk J. Tracking the dose distribution in radiation therapy by accounting for variable anatomy. Phys Med Biol. 2004;49:791-805.
73. Shah AP, Langen KM, Ruchala KJ, Cox A, Kupelian PA, Meeks SL. Patient dose from megavoltage computed tomography imaging. Int J Radiat Oncol Biol Phys 2008;70:1579-87.
74. Walter C, Boda-Heggemann J, Wertz H, Loeb I, Rahn A, Lohr F, et al. Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT. Radiother Oncol 2007;85:418-23.